TNFSF11 and osteoporosis: Recent advances in developing anti-osteoporosis drugs have resulted in both anti-resorptive agents such as bisphosphonate or anti-RANKL antibodies, and bone-forming drugs, such as teriparatide47, 48, 49, 50.